ID
24265
Description
NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection
Keywords
Versions (1)
- 7/28/17 7/28/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 28, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Randomisation Visit URINALYSIS LOCAL NCT00079911
GSK Study Randomisation Visit URINALYSIS LOCAL NCT00079911
- StudyEvent: ODM
Description
URINALYSIS - LOCAL
Description
Date sample taken
Data type
date
Measurement units
- DD/MMM/YY
Alias
- UMLS CUI [1,1]
- C1302413
- UMLS CUI [1,2]
- C0042036
Description
If positive, record results of individual tests below.
Data type
text
Alias
- UMLS CUI [1,1]
- C1160927
- UMLS CUI [1,2]
- C0456984
Description
Blood urine test
Data type
text
Alias
- UMLS CUI [1]
- C0202514
Description
Protein urine test
Data type
text
Alias
- UMLS CUI [1]
- C0262923
Similar models
GSK Study Randomisation Visit URINALYSIS LOCAL NCT00079911
- StudyEvent: ODM
C0042036 (UMLS CUI [1,2])